Catherine Murphy
Acute Care · Mechanicsville, VANPI 1346448495
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,910 of the $5,674 with a category attached, or 86.5%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $35.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Johnson & Johnson$743
- AstraZeneca$584
- Boehringer Ingelheim$535
- Amgen$383
- Boston Scientific$278
- plus $2K from 22 others
What the payments were for
- Speaking & faculty fees$75013%
- Food & beverage$4,91087%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 23 | $1,196 |
| Johnson & Johnson | 21 | $743 |
| AstraZeneca | 20 | $584 |
| Boehringer Ingelheim | 7 | $535 |
| Amgen | 7 | $383 |
| Boston Scientific | 3 | $278 |
| Merck | 9 | $224 |
| Novartis | 13 | $214 |
| Alnylam Pharmaceuticals Inc. | 6 | $211 |
| Pfizer | 7 | $192 |
| Bayer | 5 | $185 |
| Edwards Lifesciences | 3 | $169 |
| AbbVie | 7 | $132 |
| Sanofi-aventis U.S. LLC | 4 | $104 |
| Baxter Healthcare | 2 | $87 |
| Abbott | 3 | $61 |
| E.r. Squibb & Sons, L.L.C. | 4 | $55 |
| Kestra Medical Technology Services, Inc. | 2 | $45 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $44 |
| Impulse Dynamics (USA) Inc. | 2 | $40 |
| Abiomed | 2 | $39 |
| Novo Nordisk | 2 | $35 |
| Bridgebio Pharma, Inc. | 2 | $28 |
| Cardiva Medical, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 2 | $17 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,674 in reported general payments places this provider in the 90th percentile of 599 acute care providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 58 | $66,663 |
| EliquisApixaban | 49 | $55,446 |
| XareltoRivaroxaban | 19 | $29,648 |
| FarxigaDapagliflozin Propanediol | 14 | $12,967 |
| Midodrine Hcl | 23 | $1,418 |
| Metoprolol Succinate | 137 | $1,354 |
| Losartan Potassium | 112 | $673 |
| Amlodipine Besylate | 117 | $640 |
| Flecainide Acetate | 22 | $526 |
| ClopidogrelClopidogrel Bisulfate | 48 | $442 |
| Valsartan | 23 | $428 |
| Dilt-XrDiltiazem Hcl | 14 | $398 |
| Dofetilide | 11 | $395 |
| Amiodarone Hcl | 12 | $342 |
| Lisinopril | 43 | $331 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $214 | $66,66358 claims |
| PfizerEliquis | $192 | $55,44649 claims |
| Johnson & JohnsonXarelto | $743 | $29,64819 claims |
| AstraZenecaFarxiga | $584 | $12,96714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 599 acute care providers in Virginia.
Other acute care in Mechanicsville
- Larissa RodriguezMechanicsville$9K
- Jennifer KarabinMechanicsville$8K
- Jamie TempleMechanicsville$7K
- Rachel DukeRichmond$751K
- Julia KingNorfolk$99K
- Sarah KennedyNorfolk$57K
- Sarah W ShermanNorth Chesterfield$41K
- Tamara StephensDeltaville$30K
- Debra CastnerNassawadox$28K
- Linda HartMidlothian$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.